EIM
SONM icon

Essex Investment Management’s DNA X Inc SONM Stock Holding History

Essex Investment Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-53
Closed -$1.21M – 500
2019
Q2 		$1.21M Buy
+53
New +$1.34M 0.17% 194

Other funds holding SONM

NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Essex Investment Management's SONM Position: Q3 2019 in Review

Essex Investment Management sold out of DNA X Inc (SONM) in Q3 2019, closing a stake of 53 shares — an estimated $1.21M sold.

Essex Investment Management first reported a position in SONM in Q2 2019 and held it in 1 quarter. The position peaked at $1.21M in Q2 2019. 33 funds tracked by Wall St. Rank hold SONM as of Q3 2019.

  • Essex Investment Management reported no remaining DNA X Inc position as of Q3 2019 after selling out during the quarter.
  • Essex Investment Management sold 53 DNA X Inc shares in Q3 2019, an estimated $1.21M.
  • Essex Investment Management first reported a position in DNA X Inc in Q2 2019 and held it in 1 quarter.
  • Essex Investment Management's DNA X Inc position peaked at $1.21M in Q2 2019.
  • 33 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2019.

Based on Essex Investment Management's 13F filing for Q3 2019, filed 22 Oct 2019.